Dr. Tresa M. McGranahan, MD, PhD

Dr. McGranahan practices at Scripps Clinic in Encinitas, California.

Dr. McGranahan's NPI, 1639519010, was assigned on June 28, 2013. Dr. McGranahan graduated from UC San Diego School of Medicine in 2013. Dr. McGranahan holds California license A132038.

Dr. McGranahan's primary practice is Scripps Clinic, at 326 Santa Fe Dr, Encinitas, CA 92024 in San Diego County. The practice phone is (858) 554-9100.

Dr. McGranahan's primary practice is Scripps Clinic in Encinitas, California. Dr. McGranahan is also affiliated with Scripps Memorial Hospital Encinitas. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. McGranahan to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGranahan practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. McGranahan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. McGranahan is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. McGranahan's licenses on file in 5 states: California, Montana, Alaska, Idaho and Washington.

Dmand AI lists epilepsy and fibromyalgia and chronic pain among the conditions Dr. McGranahan treats.

CMS data shows 914 Medicare services from Dr. McGranahan across 8 procedure codes in 2024, for 186 Medicare patients. Medicare paid $98,761 for them.

CMS counts 186 Medicare patients who saw Dr. McGranahan in 2024. The largest group is 65 to 74, with 80 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McGranahan's median patient age at 63, with 60% women.

In 2024, Dr. McGranahan wrote 501 Medicare Part D claims for 96 patients. 95% of them were for generic drugs. CMS names the drug for 385 of them, across 16 drugs with 11 or more claims each, at $23,332 in total drug cost. In 2023, CMS named 242 claims across 7 drugs.

Dr. McGranahan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGranahan as offering telehealth.

Dmand AI links 18 papers to Dr. McGranahan, published from 2011 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Brain Neoplasms, Glioma and Neoplasm Grading. Dr. McGranahan has published most often in J Neurooncol. Dr. McGranahan's most frequent co-authors are Lia Moriguchi Halasz, MD, Seema Nagpal, MD and Lynne P. Taylor, MD.

Dmand AI links Dr. McGranahan to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Glioblastoma, Glioma and Astrocytoma.

CMS Open Payments shows 48 general payments to Dr. McGranahan from 14 drug and device companies from 2022 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 50% of the total. Servier Pharmaceuticals LLC paid the most, $52,436.

Dr. McGranahan graduated from UC San Diego School of Medicine in 2013.

Dr. McGranahan is in network with 7 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.